Alimera Sciences Statistics Share Statistics Alimera Sciences has 54.38M
shares outstanding. The number of shares has increased by 0%
in one year.
Shares Outstanding 54.38M Shares Change (YoY) 0% Shares Change (QoQ) 0% Owned by Institutions (%) 85.26% Shares Floating 13.18M Failed to Deliver (FTD) Shares 3,404,657 FTD / Avg. Volume 392.77%
Short Selling Information The latest short interest is 578.74K, so 0% of the outstanding
shares have been sold short.
Short Interest 578.74K Short % of Shares Out n/a Short % of Float n/a Short Ratio (days to cover) 1
Valuation Ratios The PE ratio is -5.49 and the forward
PE ratio is 12.88.
Alimera Sciences's PEG ratio is
0.08.
PE Ratio -5.49 Forward PE 12.88 PS Ratio 1.37 Forward PS 2.1 PB Ratio 2.39 P/FCF Ratio -1.23 PEG Ratio 0.08
Financial Ratio History Enterprise Valuation Currently the Enterprise Value (EV) is not available for Alimera Sciences.
EV / Sales n/a EV / EBITDA n/a EV / EBIT n/a EV / FCF n/a
Financial Position The company has a current ratio of 2.39,
with a Debt / Equity ratio of 1.46.
Current Ratio 2.39 Quick Ratio 2.31 Debt / Equity 1.46 Debt / EBITDA -60.45 Debt / FCF -0.75 Interest Coverage -0.19
Financial Efficiency Return on Equity is n/a and Return on Invested Capital is n/a.
Return on Equity n/a Return on Assets n/a Return on Invested Capital n/a Revenue Per Employee $524.38K Profits Per Employee $-130.73K Employee Count 154 Asset Turnover 0.53 Inventory Turnover 10.42
Taxes Income Tax 85K Effective Tax Rate -0.42%
Stock Price Statistics The stock price has increased by -1.07% in the
last 52 weeks. The beta is 1.25, so Alimera Sciences's
price volatility has been higher than the market average.
Beta 1.25 52-Week Price Change -1.07% 50-Day Moving Average 5.56 200-Day Moving Average 4.21 Relative Strength Index (RSI) 52.49 Average Volume (20 Days) 866,825
Income Statement In the last 12 months, Alimera Sciences had revenue of 80.75M
and earned -20.13M
in profits. Earnings per share was -0.79.
Revenue 80.75M Gross Profit 61.17M Operating Income -1.93M Net Income -20.13M EBITDA -1.11M EBIT -9.86M Earnings Per Share (EPS) -0.79
Full Income Statement Balance Sheet The company has 12.09M in cash and 67.4M in
debt, giving a net cash position of -55.31M.
Cash & Cash Equivalents 12.09M Total Debt 67.4M Net Cash -55.31M Retained Earnings -418.49M Total Assets 150.38M Working Capital 35.57M
Full Balance Sheet Cash Flow In the last 12 months, operating cash flow was -14.26M
and capital expenditures -75.53M, giving a free cash flow of -89.79M.
Operating Cash Flow -14.26M Capital Expenditures -75.53M Free Cash Flow -89.79M FCF Per Share -3.51
Full Cash Flow Statement Margins Gross margin is 75.75%, with operating and profit margins of -2.39% and -24.93%.
Gross Margin 75.75% Operating Margin -2.39% Pretax Margin -24.82% Profit Margin -24.93% EBITDA Margin -1.38% EBIT Margin -2.39% FCF Margin -111.19%
Dividends & Yields ALIM does not appear to pay any dividends at this time.
Dividend Per Share n/a Dividend Yield n/a Dividend Growth (YoY) n/a Payout Ratio n/a Earnings Yield n/a FCF Yield n/a
Dividend Details Analyst Forecast The average price target for ALIM is $6,
which is 8.3% higher than the current price. The consensus rating is "Hold".
Price Target $6 Price Target Difference 8.3% Analyst Consensus Hold Analyst Count 3
Stock Forecasts Fair Value There are several formulas that can be used to estimate the
intrinsic value of a stock.
Lynch Fair Value n/a Lynch Upside n/a Graham Number n/a Graham Upside n/a
Stock Splits The last stock split was on Nov 15, 2019. It was a
backward
split with a ratio of 1:15.
Last Split Date Nov 15, 2019 Split Type backward Split Ratio 1:15
Scores Altman Z-Score -1.44 Piotroski F-Score 1
